Exelixis (EXEL) Cost of Revenue (2013 - 2026)

Exelixis (EXEL) recorded quarterly Cost of Revenue of $20.0 million in Q2 2026, down 24.65% quarter-over-quarter from $26.5 million in Q1 2026, and up 4.07% on a YoY basis from $19.2 million in Q2 2025.

Exelixis (EXEL) Cost of Revenue (2013 - 2026) Analysis & Trends

Exelixis' Cost of Revenue history runs 14 years deep, the most recent figure standing at $20.0 million for Q2 2026.

  • In Q2 2026, Cost of Revenue rose 4.07% year-over-year to $20.0 million; the TTM figure through Apr 2026 stood at $84.5 million (up 13.96% YoY), while the FY2026 annual figure was $83.7 million, up 9.82% from the prior year.
  • Cost of Revenue was $20.0 million for Q2 2026 at Exelixis, down from $26.5 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $26.5 million in Q1 2026 to a low of $13.2 million in Q2 2022.
  • Historically, Cost of Revenue has averaged $18.3 million across 5 years, with a median of $18.6 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Cost of Revenue surged 48.49% in 2024, then dropped 9.8% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $15.9 million in 2022, then surged by 36.64% to $21.8 million in 2023, then declined by 20.34% to $17.3 million in 2024, then climbed by 7.19% to $18.6 million in 2025, then grew by 7.42% to $20.0 million in 2026.
  • The last three Cost of Revenue figures came in at $20.0 million (Q2 2026), $26.5 million (Q1 2026), and $18.6 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 64.20 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 48,670.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 392.80 Mn
9 Abivax 91.71 Bn 91.71 Bn - 2.05 Mn
10 Exelixis 13.61 Bn 12.83 Bn 590.86 Mn 19.95 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 19.95 Mn
Apr 3, 2026 19.95 Mn
Jan 2, 2026 26.48 Mn
Jan 2, 2026 26.48 Mn
Oct 3, 2025 18.57 Mn
Oct 3, 2025 18.57 Mn
Jul 4, 2025 19.47 Mn
Jul 4, 2025 19.47 Mn
Apr 4, 2025 19.17 Mn
Apr 4, 2025 19.17 Mn
Jan 3, 2025 19.97 Mn
Jan 3, 2025 19.97 Mn
Sep 27, 2024 17.33 Mn
Sep 27, 2024 17.33 Mn
Jun 28, 2024 17.67 Mn
Jun 28, 2024 17.67 Mn
Mar 29, 2024 21.26 Mn
Mar 29, 2024 21.26 Mn
Dec 29, 2023 21.75 Mn
Dec 29, 2023 21.75 Mn